This website is for Private Investors* only

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

Obtains access to the information in a personal capacity;

Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;

Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;

Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;

Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;

Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.

Banking

Energy Producers

Engineering

Mining

Economy

Market Report

Companies

Currencies

Asia report: Markets rise on positive Covid vaccine developments

March 3, 2020, Shanghai China - A doctor wears a surgical mask as protection against the coronavirus outsiode Zhongshan Hospital in Xuhui Disrtrict. According to official figures more than 93,000 people have been infected with the virus and at least 3,100Dave Tacon

Markets in Asia were sparkling green across the board as they closed on Tuesday, as investors cheered positive phase one results for a potential Covid-19 coronavirus vaccine from US firm Moderna Therapeutics overnight.

In Japan, the Nikkei 225 was up 1.49% at 20,433.45, as the yen weakened 0.19% against the greenback to last trade at JPY 107.54.

Technology giant SoftBank Group was down 2.75%, while among the benchmark’s other main components, automation specialist Fanuc was up 3.99%, and Uniqlo owner Fast Retailing was 0.64% higher.

The broader Topix index managed gains of 1.83% by the end of trading in Tokyo, closing at 1,486.05.

On the mainland, the Shanghai Composite was ahead 0.81% at 2,898.58, and the smaller, technology-heavy Shenzhen Composite was 1.26% firmer at 1,823.57.

China’s president Xi Jinping also piled on support for the global pandemic that began in the country, pledging $2bn in the next two years to help other nations deal with the impact of the virus.

South Korea’s Kospi leapt 2.25% to 1,980.61, while the Hang Seng Index in Hong Kong added 1.89% to 24,388.13.

Both of the blue-chip technology stocks were positive in Seoul, with Samsung Electronics up 3.07%, and chipmaker SK Hynix rising 1.97%.

Carmaker Hyundai Motor was also well into the green, rocketing 7.83% by the close of business.

Hong Kong-listed shares in British banking giant HSBC were also well ahead, rising 3.27% by the end of the day.

Sentiment was simmering at a satisfying pace globally during the Asian day, after US firm Moderna reported positive phase one results for its coronavirus vaccine candidate.

The company said that after two doses, all 45 participants in the trial had developed coronavirus antibodies.

“The icing on the cake was when Moderna announced that its potential Covid-19 vaccine showed positive results in phase one of the human trials,” explained CMC Markets analyst David Madden.

“The next phase of trials will be undertaken soon, while the third phase of trials - which will include thousands of patients - might be conducted in July.

“The bullish sentiment in the US spilled over to Asia as hopes for a vaccine lifted stock markets in China and Japan.”

Oil prices were lower at the end of the Asian day, with Brent crude last down 0.72% at $34.56 per barrel, and West Texas Intermediate losing 0.51% to $31.49.

In Australia, the S&P/ASX 200 rose 1.81% to 5,559,50, as investors in Sydney pored through the minutes of the Reserve Bank of Australia’s May meeting.

The central bank said it “would not increase the cash rate target until progress is made towards full employment, and its is confident that inflation will be sustainably within the 2% to 3% target range”.

Australia’s cash rate currently stands at a record low 0.25%, having been slashed in a special announcement on 19 March and reaffirmed twice since then.

Across the Tasman Sea, New Zealand’s S&P/NZX 50 was 0.3% higher at 10,790.14, led higher by specialist dairy processor Synlait Milk, which was up 4.9%.

Both of the down under dollars were stronger on the greenback, with the Aussie last ahead 0.25% at AUD 1.5289, and the Kiwi advancing 0.69% to NZD 1.6441.